author-photo

Ernst-Wilhelm Radue

University of Basel

219

Papers

14190

Citations

Citation Trend

Filter By

Papers (153) Sort By

Journal Conference Others

Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial.

2021 Lancet Neurology
Show All
- Source
- Cite
- Save
Citations (1)
Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging.

2021 Brain
Show All
- Source
- Cite
- Save
Citations (8)
White matter lesion location correlates with disability in relapsing multiple sclerosis

2020
Show All
- Source
- Cite
- Save
Citations (0)
Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study.

2020 Journal of Neurology
Show All
- Source
- Cite
- Save
Citations (4)
Accurate, rapid and reliable, fully automated MRI brainstem segmentation for application in multiple sclerosis and neurodegenerative diseases

2019 Human Brain Mapping
Show All
- Source
- Cite
- Save
Citations (11)
Safety and Efficacy of Long-Term Treatment With Daclizumab Beta: 6-Year Results From the SELECTED Extension Study (P6.390)

2018 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
Clinical Correlations of Brain Lesion Location in Multiple Sclerosis: Voxel-Based Analysis of a Large Clinical Trial Dataset

2018 Brain Topography
Show All
- Source
- Cite
- Save
Citations (12)
A comparison of multiple sclerosis disease activity after discontinuation of fingolimod and placebo

2017
Show All
- Source
- Cite
- Save
Citations (21)
Teriflunomide slows BVL in relapsing MS: A reanalysis of the TEMSO MRI data set using SIENA

2017 Neuroimmunology and Neuroinflammation
Show All
- Source
- Cite
- Save
Citations (47)
Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.

2017 Multiple Sclerosis Journal
Show All
- Source
- Cite
- Save
Citations (25)